Efficacy of recombinant human mannose binding lectin alone and in combination with itraconazole against murine Candida albicans vaginitis

Immunological Investigations

Volumn 40, Issue 6, 2011, Pages 553-568

  Clemons, Karl V ^a,b,c   Martinez, Marife ^a   Axelsen, Mads ^d   Thiel, Steffen ^e   Stevens, David A ^a,b,c  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NatImmune A/S   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

Author keywords

Candida albicans; Candidal vaginitis; Mannose binding lectin; MBL; vaginitis

Indexed keywords

ANTIFUNGAL AGENT; CLOTRIMAZOLE; ITRACONAZOLE; LECTIN; PLACEBO; RECOMBINANT HUMAN MANNOSE BINDING LECTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG TISSUE LEVEL; FEMALE; LUNG LAVAGE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINAL LAVAGE; VIRAL CLEARANCE;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ANIMALS; BODY FLUIDS; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; ITRACONAZOLE; MANNOSE-BINDING LECTIN; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOMBINANT PROTEINS; TREATMENT OUTCOME; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES; VAGINAL DOUCHING;

EID: 79959623805     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2011.569627     Document Type: Article

References (26)

1. Babula, O., Lazdane, G., Kroica, J., Ledger, W. J., Witkin, S. S. (2003). Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin. Infect. Dis. 37: 733-737. (Pubitemid 37100818)
2. Brouwer, N., Dolman, K. M., van Houdt, M., Sta, M., Roos, D., Kuijpers, T. W. (2008). Mannose-Binding Lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding. J. Immunol. 180:4124-4132.
3. Brummer, E., Stevens, D. A. (2010). Collectins and fungal pathogens: role of surfactant proteins and mannose binding lectin in host resistance. Med. Mycol. 48:16-28.
4. Calderon, L., Williams, R., Martinez, M., Clemons, K. V., Stevens, D. A. (2003). Genetic susceptibility to vaginal candidiasis. Med. Mycol. 41:143-147. (Pubitemid 41001692)
5. Capilla, J., Clemons, K. V., Stevens, D. A. (2007). Animal models: an important tool in mycology. Med. Mycol. 45:657-684. (Pubitemid 350153959)
6. Christiansen, O. B., Kilpatrick, D. C., Souter, V., Varming, K., Thiel, S., Jensenius, J. C. (1999). Mannan-binding lectin deficiency is associated with unexplained recurrent miscarriage. Scand. J. Immunol. 49:193-196. (Pubitemid 29096316)
7. Clemons, K. V., Gonzalez, G. M., Singh, G., Imai, J., Espiritu, M., Parmar, R., Stevens, D. A. (2006). Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs. Antimicrob. Agents Chemother. 50:2650-2657. (Pubitemid 44198683)
8. Clemons, K. V., Spearow, J. L., Parmar, R., Espiritu, M., Stevens, D. A. (2004). Genetic susceptibility of mice to Candida albicans vaginitis correlates with host estrogen sensitivity. Infect. Immun. 72:4878-4880. (Pubitemid 38989350)
9. Donders, G. G., Babula, O., Bellen, G., Linhares, I. M., Witkin, S. S. (2008). Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis. B.J.O.G. 115:1225-1231.
10. Eisen, D. P., Minchinton, R. M. (2003). Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin. Infect. Dis. 37:1496-1505. (Pubitemid 37494678)
11. Frakking, F. N., Brouwer, N., van de Wetering, M. D., Budde, I. K., Strengers, P. F., Huitema, A. D., Laursen, I., Houen, G., Caron, H. N., Dolman, K. M., Kuijpers, T. W. (2009). Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia. Eur. J. Cancer 45:505-512.
12. Ip,W. K., Lau, Y. L. (2004). Role of mannose-binding lectin in the innate defense against Candida albicans: enhancement of complement activation, but lack of opsonic function, in phagocytosis by human dendritic cells. J. Infect. Dis. 190:632-640.
13. Jensenius, J. C., Jensen, P. H., McGuire, K., Larsen, J. L., Thiel, S. (2003). Recombinant mannan-binding lectin (MBL) for therapy. Biochem. Soc. Transact. 31:763-767. (Pubitemid 36981121)
14. Lee, S. J., Gonzalez-Aseguinolaza, G., Nussenzweig, M. C. (2002). Disseminated candidiasis and hepatic malarial infection in mannose-binding- lectin-A-deficient mice. Mol. Cell. Biol. 22:8199-8203. (Pubitemid 35304053)
15. Lee, S. J., Zheng, N. Y., Clavijo, M., Nussenzweig, M. C. (2003). Normal host defense during systemic candidiasis in mannose receptor-deficient mice. Infect. Immun. 71:437-445. (Pubitemid 36026048)
16. Lillegard, J. B., Sim, R. B., Thorkildson, P., Gates, M. A., Kozel, T. R. (2006). Recognition of Candida albicans by mannan-binding lectin in vitro and in vivo. J. Infect. Dis. 193:1589-1597. (Pubitemid 43794589)
17. Liu, F., Liao, Q., Liu, Z. (2006). Mannose-binding lectin and vulvovaginal candidiasis. Int. J. Gynaecol. Obstet. 92:43-47. (Pubitemid 41773716)
18. Liu, H., Jensen, L., Hansen, S., Petersen, S. V., Takahashi, K., Ezekowitz, A. B., Hansen, F. D., Jensenius, J. C., Thiel, S. (2001). Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses. Scand. J. Immunol. 53:489-497. (Pubitemid 32382273)
19. Pellis, V., De Seta, F., Crovella, S., Bossi, F., Bulla, R., Guaschino, S., Radillo, O., Garred, P., Tedesco, F. (2005). Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina. Clin. Exp. Immunol. 139:120-126. (Pubitemid 40066136)
20. Petersen, K. H. Matthiesen, F., Agger, T., Kongerslev, L., Thiel, S., Cornelissen, K., Axelsen, M. (2006). Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. J. Clin. Immunol. 26: 564-575.
21. Petersen, S. V., Thiel, S., Jensen, L., Vorup-Jensen, T., Koch, C., Jensenius, J. C. (2000). Control of the classical and the MBL pathway of complement activation. Mol. Immunol. 37:803-811.
22. Shi, L., Takahashi, K., Dundee, J., Shahroor-Karni, S., Thiel, S., Jensenius, J. C., Gad, F., Hamblin, M. R., Sastry, K. N., Ezekowitz, R. A. (2004). Mannose-binding lectindeficient mice are susceptible to infection with Staphylococcus aureus. J. Exp. Med. 199: 1379-1390. (Pubitemid 38685729)
23. Stevens, D. A., Brummer, E., Clemons, K. V. (2006). Interferon-gamma as an antifungal. J. Infect. Dis. 194(Suppl 1): S33-37.
24. Stevens, D. A., Calderon, L., Martinez, M., Clemons, K. V., Wilson, S. J., Selitrennikoff, C. P. (2002). Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model. J. Antimicrob. Chemother. 50: 361-364.
25. Sugar, A. M., Brummer, E., Stevens, D. A. (1983). Murine pulmonary macrophages: evaluation of lung lavage fluids, miniaturized monolayers, and candidacidal activity. Am. Rev. Respir. Dis. 127: 110-112. (Pubitemid 13168323)
26. Thiel, S., Frederiksen, P. D., Jensenius, J. C. (2006). Clinical manifestations of mannanbinding lectin deficiency. Mol. Immunol. 43: 86-96. (Pubitemid 41021525)